David is a Board Member of the International Trade Institute. He has vast experience in the pharmaceutical industry. David is a former member of the Executive Committee of Horizon Therapeutics, plc, a biopharmaceutical company listed on Nasdaq and headquartered in Dublin, and he currently serves as a director of its Irish operating subsidiary. He also serves on the board of Iterum Therapeutics, plc (also Nasdaq listed) and chairs its audit committee. David holds a Bachelor's degree in Economics from Trinity College Dublin and is also a member of the Institute of Chartered Accountants in Ireland (ACA).